Key facts
- Notable investors include Zhongshan Finance Investment, Taicang Hongrun Private Equity Fund Management.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Shanghai Baiyi Medical Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Shanghai Baiyi Medical Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Shanghai Baiyi Medical Technology
Developer of diagnostic medical devices designed to advance the clinical assessment of thyroid-related ocular conditions. The company offers AI-assisted measurement systems, standardized quantification tools, and precision imaging technologies, enabling endocrinologists and ophthalmologists, accurately evaluate disease and improve therapeutic outcomes.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2020
- Website
- baiyi-healthcare.com/
- Ownership
- Privately Held (backing)
Shanghai Baiyi Medical Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Shanghai Baiyi Medical Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Shanghai Baiyi Medical Technology in its N-PORT filings yet. We sweep new filings monthly.